تأثیر کرم واژینال رازیانه بر دیسپارونی و رضایت جنسی زنان یائسه: یک کارآزمایی بالینی تصادفی دوسوکور کنترل شده

نوع مقاله: اصیل پژوهشی

نویسندگان

1 مربی گروه مامایی، مرکز تحقیقات یائسگی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی جندی شاپور اهواز، اهواز، ایران.

2 کارشناس ارشد مامایی، مرکز تحقیقات یائسگی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی جندی شاپور اهواز، اهواز، ایران.

3 دانشیار گروه مامایی، مرکز تحقیقات یائسگی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی جندی شاپور اهواز، اهواز، ایران.

4 استادیار گروه داروسازی، دانشکده داروسازی، دانشگاه علوم پزشکی جندی شاپور اهواز، اهواز، ایران.

5 استادیار گروه آمار و اپیدمیولوژی، دانشکده بهداشت، دانشگاه علوم پزشکی جندی شاپور اهواز، اهواز، ایران.

چکیده

مقدمه: در یائسگی کاهش استروژن و آندروژن به طور فیزیولوژیک منجر به کاهش جریان خون ناحیه ولو و واژن و در نتیجه کاهش میل و برانگیختگی جنسی می شود و خشکی واژن باعث کاهش آستانه حسی ناحیه ژنیتال، دیسپارونی و کاهش لیبیدو می شود، رضایت از رابطه جنسی در سلامت روحی افراد نقش بسزایی دارد. مطالعه حاضر با هدف بررسی تأثیر کرم واژینال رازیانه بر مقاربت دردناک و رضایت جنسی زنان یائسه انجام شد.
روش کار: این مطالعه کارآزمایی بالینی دوسوکور در سال 1393 با هدف بررسی تأثیر مصرف کرم واژینال رازیانه بر رضایت جنسی زنان یائسه بر روی 60 زن مراجعه‌کننده به مرکز بهداشتی شماره یک شرق اهواز انجام شد. تعداد 60 زن یائسه با تشخیص آتروفی واژن به صورت تصادفی در دو گروه 30 نفری جهت دریافت کرم واژینال رازیانه 5% و دارونما برای مدت 8 هفته قرار گرفتند. میزان رضایت جنسی بر اساس پرسشنامه لارسون محاسبه شد. تجزیه و تحلیل داده‌ها با استفاده از نرم افزار آماری SPSS (نسخه 22) و آزمون‌ های تی زوجی، تی مستقل، کای دو، من ویتنی و معادلات برآورد تعمیم یافته (GEE) انجام شد. میزان p کمتر از 05/0 معنی‌دار در نظر گرفته شد.
یافته‌ها: پس از مداخله، میانگین میزان رضایت جنسی در افراد گروه مصرف کننده کرم واژینال رازیانه به طور معنی‌داری بهتر از گروه دارونما بود (001/0>p) و کاهش قابل توجهی در درد حین مقاربت در گروه مصرف کننده کرم واژینال رازیانه مشاهده شد.
نتیجه‌گیری: مصرف کرم واژینال رازیانه سبب کاهش مقاربت دردناک و افزایش رضایت جنسی در زنان یائسه می شود.
 

کلیدواژه‌ها


عنوان مقاله [English]

Effect of Fennel vaginal cream on dysparonia and sexual satisfaction among postmenopausal women: A double-blind randomized controlled trial

نویسندگان [English]

  • Shahnaz Najar 1
  • Masomeh Yaralizadeh 2
  • Parvin Abedi 3
  • Foroogh Namjooyan 4
  • omol Malehi 5
1 Instructor, Department of Midwifery, Menopause Research Center, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
2 M.Sc. of Midwifery, Menopause Research Center, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
3 Associate professor, Department of Midwifery, Menopause Research Center, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
4 Assistant Professor, Department of Pharmacology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
5 Assistant Professor, Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
چکیده [English]

Introduction: In menopause, decreased estrogen and androgen physiologically levels leads to decrease in blood flow to the vulva and vagina, and thus reducing sexual desire and arousal. Vaginal dryness can decrease sensory threshold of genital area, dyspareunia and reduced libido. The satisfaction in sexual relationship has an important role in mental health of people.This study was performed with aim to evaluate the effect of fennel vaginal cream on dyspareunia and sexual satisfaction among postmenopausal women.
Methods: This randomized, double-blind controlled trial was performed on 60 postmenopausal women referred to No 1 Eastern health center in Ahvaz with aim to evaluate the effect of fennel vaginal cream on sexual satisfaction in 2014. Sixty postmenopausal women with diagnosis of vaginal atrophy were randomly divided into two 30 cases groups to receive fennel vaginal cream 5% and placebo for 8 weeks. The sexual satisfaction was measured using Larson Questionnaire. Data were analyzed using SPSS software (version 22), and paired t-test, independent t-test, Chi-square, Mann-Whitney and GEE. PResults: After the intervention, sexual satisfaction was significantly improved in fennel vaginal cream group than placebo group (P<0.001), and a significant reduction in dysparonia was observed in fennel vaginal cream (P<0.05).
Conclusion: The results of the study showed that use of fennel vaginal cream was effective in reducing dysparonia and increasing sexual satisfaction.

کلیدواژه‌ها [English]

  • Dysparonia
  • Fennel vaginal cream
  • Menopause
  • Sexual satisfaction
  1. Salehi K, Ehsanpour S, Zolfaghari B, Salehi Z, Honargoo M. Effect of red clover Isoflavones extract on menopausal symptoms. J Gorgan Univ Med Sci 2013; 5(2):21–7. (Persian).
  2. Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 2010; 67(3):233–8.
  3. Semmens JP, Wagner G. Estrogen deprivation and vaginal function in postmenopausal women. JAMA 1982; 248(4):445–8.
  4. Stanhopse M, Lancaster J. Community & public health nursing. St Louis: Mosby Co; 2000. P. 572.
  5. Nouhjah S, Mohammad JR, Latifi S. The mean age of menopause and its determinant factors: a cross-sectional study in Ahwaz. Jundishapur Sci Med J 2005; 4(46):216-22.
  6. Castiglione C, Licciardello O, Rampullo A, Campione C. Representation of future changes in menopausal women. Procedia Soc Behav Sci 2014; 116:4993–7.
  7. Novak E. Berek & Novak’s gynecology. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. P. 1323-38.
  8. Palacios S. Androgens and female sexual function. Maturitas 2007; 57(1):61–5.
  9. Long CY, Liu CM, Hsu SC, Wu CH, Wang CL, Tsai E. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause 2006; 13(5):737–43.
  10. Bygdeman M, Swahn ML. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 1996; 23(3):259–63.
  11. Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal Changes) survey. J Sex Med 2013; 10(7):1790–9.
  12. Labrie F, Archer DF, Bouchard C, Girard G, Ayotte N, Gallagher JC, et al. Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas 2015; 81(1):46-56.
  13. Krapf JM, Belkin ZR, Goldstein AT. Advances in the treatment of vulvovaginal atrophy. Expert Rev Obstet Gynecol 2013; 8(5):457–65.
  14. Karimi A, Dadgar S, Afiat M, Rahimi N. The effect of sexual health education on couples sexual satisfaction. Iran J Obestet Gynecol Infertil 2013; 15(42):23–30. (Persian).
  15. Utian WH, Maamari R. Attitudes and approaches to vaginal atrophy in postmenopausal women : a focus group qualitative study. Climacteric 2014; 17(1):29–36.
  16. Poluzzi E, Piccinni C, Raschi E, Rampa A, Recanatini M, De Ponti F. Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective. Curr Med Chem 2014; 21(4):417–36.
  17. Lima SM, Yamada SS, Reis BF, Postigo S, Galvão Da Silva MA, Aoki T. Effective treatment of vaginal atrophy with isoflavone vaginal gel. Maturitas 2013; 74(3):252–8.
  18. Jefferson WN, Pedilla-Banks E, Newbold RR. Disruption of the female reproductive system by the phytoestrogen genisrein. Reprod Toxicol 2007; 23(3):308-16.
  19. Lof M, Weiderpass E. Epidemiologic evidence suggests that dietary phytoestrogen intake is associated with reduced risk of breast, endometrial, and prostate cancers. Nutrit Res 2006; 26(12):609-19.
  20. Chen LC, Wang BR, Chen IC, Shao CH. Use of Chinese herbal medicine among menopausal women in Taiwan. Int J Gynaecol Obstet 2010; 109(1):63–6.
  21. He W, Huang B. A review of chemistry and bioactivities of medicinal spice: Foeniculum vulgare. J Med Plants Res 2011; 5(16):3595–600.
  22. Krenn L, Unterrider I, Ruprechter R. Quantification of isoflavones in red clover by high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 777(1-2):123–8.
  23. Barrett B. Complementary and alternative medicine: What’s it all about? WMJ 2001; 100(7):20–6.
  24. Appt SE. Usefulness of the monkey model to investigate the role of soy in postmenopausal women's health. ILAR J 2004; 45(2):200–11.
  25. Booth NL, Piersen CE, Banuvar S, Geller SE, Shulman LP, Farnsworth NR. Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review. Menopause 2006; 13(2):251–64.
  26. Sefidcan F. Qualitative and quantitative study of fennel in various stages of growth. Iran J Med Aromat Plants 2001; 10(12):85–104.
  27. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignin production from various foods. Nutr Cancer 1991; 16(1):43–52.
  28. Namavar Jahromi B, Tartifizadeh A, Khabnadideh S. Comparison of fennel and mefenamic acid for the treatment of primary dysmenorrheal. Int J Gynecol Obstet 2003; 80(2):153–7.
  29. Malini T, Vanithakumari G, Megala N, Anusya S, Devi K, Elango V. Effect of Foeniculum vulgar Mill. seed extract on the genital organs of male and female rats. Indian J Physiol Pharmacol 1985; 29(1):21–6.
  30. Jaffary F, Ghannadi A, Najafzadeh H. Evaluation of the prophylactic effect of fennel essential oil on experimental osteoporosis model in rats. Int J Pharmacol 2006; 2(5):588–92.
  31. Javidnia K, Dastgheib L, Mohammadi Samani S, Nasiri A. Antihirsutism activity of Fennel (fruits of Foeniculum vulgare) extract. A double–blind placebo controlled study. Phytomedicine 2003; 10(6-7):455–8.
  32. Savino F, Ceratto S, De Marco A, Cordero di Montezemolo L. Looking for new treatment of infantile colic. Ital J Pediat 2014; 40(1):53-9.
  33. Siahi M, Shiravi A, Heydari M. The effect of fennel hydro extract of fennel on prolactin and lactation female Rat. J Res Anim Boil Damghan 2009; 1(33):55–63. (Persian).
  34. Pazandeh F, Azar M, Ziaei T, Alavi Majd H. Survey on sexual satisfaction situation and some of affecting agents in postmenopausal women. ZUMS J 2010; 18(71):81–9. (Persian).
  35. Davaran P. Comparison of the effect of Foeniculum vulgare and St John’s wort (Hypericum perforatum) on the climacteric symptoms and sexual activity in menopausal woman attending in selected gynecology. [Tesis for Master]. Shiraz, Iran: Shiraz University of Medical Sciences; 2013. (Persian).
  36. Leiblum S, Bachman G, Kemmann E, Colburn D, Swartzman L. Vaginal atrophy in the postmenopausal woman: the importance of sexual activity and hormones. JAMA 1983; 249(16):2195–8.
  37. Brizendine L. Managing menopause-related depression and low libido. OBG Manag 2004; 16(8):29-42.
  38. Morali G, Polatti F, Metelitsa EN, Mascarucci P, Magnani P, Marre GB. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arzneimittelforschung 2006; 56(3):230–8.